Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideTMOThermo Fisher Scientific
FinDog View：Bullish
| Metric | DVA | TMO |
|---|
| Close | 193.86 | 648.43 |
| Market Cap | $12.4B | $240B |
| 1M | +9.71% | +10.75% |
| P/E (TTM) | 14.4 | 34.4 |
| Forward P/E | 13.1 | 21.8 |
| P/E 5-Yr Percentile | 30 | 65 |
| P/S | 0.9 | 5.2 |
| P/B | — | 4.6 |
| Dividend Yield | — | 0.29% |
| Latest Quarter Revenue | $3.6B | $12.0B |
| Revenue YoY | +5.2% | +10.5% |
| Gross Margin | — | — |
| Latest Quarter EPS | 4.02 | 4.68 |
| Avg Post-Earnings Move | ±12.9% | ±1.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 7.22% | 2.36% |
| 90-Day Net Insider Buying | — | −$38.9M |
DVA · Revenue, Last 8 Quarters ($B)
TMO · Revenue, Last 8 Quarters ($B)
